| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/1996 | CA2155134A1 Branched polysaccharide, microorganism producing it and compositions containing them |
| 02/20/1996 | CA2107110C Novel immunosuppressant agent from streptomyces braegensis |
| 02/20/1996 | CA2065271C New bis-platinum complexes as chemotherapeutic agents |
| 02/20/1996 | CA2029015C Pharmaceutical compositions for treating gastrointestinal distress |
| 02/18/1996 | CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication |
| 02/17/1996 | CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals |
| 02/17/1996 | CA2156128A1 Substituted quinoline derivatives, a process for their preparation, and their use |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004323A2 Gas phase production of polydienes |
| 02/15/1996 | WO1996004322A1 Gas phase production of polydienes |
| 02/15/1996 | WO1996004321A1 Gas phase polymerization process |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004296A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | WO1996004292A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1996 | WO1996004288A1 Glycine receptor antagonist pharmacophore |
| 02/15/1996 | WO1996004287A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/15/1996 | WO1996004286A1 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 02/15/1996 | WO1996004285A1 6β-SUBSTITUTED PENICILLANIC ACIDS AS β-LACTAMASE INHIBITORS |
| 02/15/1996 | WO1996004283A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 02/15/1996 | WO1996004281A1 Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines |
| 02/15/1996 | WO1996004280A1 Phenyl xanthine derivatives |
| 02/15/1996 | WO1996004277A1 Pyrrolinone-based peptidomimetics |
| 02/15/1996 | WO1996004276A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004275A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004274A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | WO1996004273A1 New pyrazole derivatives as angiotensin ii antagonist |
| 02/15/1996 | WO1996004272A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004266A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 02/15/1996 | WO1996004263A1 Method for the preparation of (±)-calanolide a and intermediates thereof |
| 02/15/1996 | WO1996004261A1 Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| 02/15/1996 | WO1996004260A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
| 02/15/1996 | WO1996004257A1 Crystalline form of an antifungal azole |
| 02/15/1996 | WO1996004254A2 Benzodiazepine derivatives |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996004247A1 Process for making antimicrobial compounds |
| 02/15/1996 | WO1996004245A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004243A1 Stable vitamin a |
| 02/15/1996 | WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents |
| 02/15/1996 | WO1996004241A2 Benzoylguanidine derivatives as medicaments |
| 02/15/1996 | WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | WO1996004230A1 Terpene-quinone with antitumor activity |
| 02/15/1996 | WO1996003998A1 Quinoa saponin compositions and methods of use |
| 02/15/1996 | WO1996003992A1 Protective prostaglandins for use in conjunction with chemotherapeutic agents |
| 02/15/1996 | WO1996003991A1 Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
| 02/15/1996 | WO1996003990A1 Optic nerve health |
| 02/15/1996 | WO1996003988A1 Process and products for reducing biological fluid levels of a lipid soluble waste |
| 02/15/1996 | WO1996003987A1 Lactone compounds for treating patients with precancerous lesions |
| 02/15/1996 | WO1996003986A1 Topical administration of calcium channel blocking agents |
| 02/15/1996 | WO1996003985A1 Topical administration of calcium channel blocking agents |
| 02/15/1996 | WO1996003984A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | WO1996003981A1 Growth stimulating factors |
| 02/15/1996 | WO1996003965A1 Method for treating non-ocular epithelial disorders |
| 02/15/1996 | WO1996003876A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
| 02/15/1996 | WO1996000726A3 New brefeldin a derivatives and their utility in the treatment of cancer |
| 02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 02/15/1996 | WO1995019169A3 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor |
| 02/15/1996 | DE4429398A1 Pharmazeutische Zusammensetzungen mit Estra-1,3,5(10)-trien-Derivaten Pharmaceutical compositions with Estra-1,3,5 (10) -triene derivatives |
| 02/15/1996 | DE4429397A1 Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1996 | DE4428444A1 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen Use of selegiline for the treatment of epileptic disorders |
| 02/15/1996 | DE4428199A1 Use of flunitrazepam and/or chloroquine |
| 02/15/1996 | CA2632452A1 Substituted o6-benzylguanines and use thereof |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196809A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | CA2196763A1 Benzoylguanidine derivatives as medicaments |
| 02/15/1996 | CA2196752A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1996 | CA2196751A1 Protective prostaglandins for use in conjunction with chemotherapeutic agents |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2196700A1 N-substituted azabicycloheptane derivatives, the preparation aand use thereof |
| 02/15/1996 | CA2196676A1 Gas phase production of polydienes |
| 02/15/1996 | CA2196675A1 Gas phase polymerization process |
| 02/15/1996 | CA2196664A1 Gas phase production of polydienes |
| 02/15/1996 | CA2196608A1 Pyrrolinone-based peptidomimetics |
| 02/15/1996 | CA2196219A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196218A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | CA2196082A1 Quinoa saponin compositions and methods of use |
| 02/15/1996 | CA2196079A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
| 02/15/1996 | CA2196062A1 Benzodiazepine derivatives |
| 02/15/1996 | CA2196039A1 Optic nerve health |
| 02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | CA2195850A1 Substituted indoles |
| 02/15/1996 | CA2195430A1 6.beta.-substituted penicillanic acids as .beta.-lactamase inhibitors |
| 02/15/1996 | CA2195107A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | CA2194567A1 Crystalline form of an antifungal azole |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2193845A1 Arylthio compounds as antibacterial and antiviral agents |
| 02/15/1996 | CA2173258A1 New pyrazole derivatives as angiotensin ii antagonist |
| 02/15/1996 | CA2173157A1 Terpene-quinone with antitumor activity |
| 02/15/1996 | CA2172986A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/15/1996 | CA2172830A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
| 02/15/1996 | CA2172710A1 Lactone compounds for treating patients with precancerous lesions |
| 02/14/1996 | EP0696598A1 Polysaccharide esters and their salts |
| 02/14/1996 | EP0696593A2 Inhibitors of farnesyl protein transferase |